# The Hartford Healthcare Fd Cl Y (HGHYX): Mutual Fund Facts & Distributions > Markdown mirror of https://www.dividenddata.com/funds/hghyx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice. - Issuer: Hartford · Asset class: Equity - Strategy: Actively Managed · Inception: 2000-04-28 The fund aims to achieve substantial long-term capital appreciation. Under normal circumstances, a minimum of 80% of its portfolio is allocated to equity holdings in global companies tied to the healthcare sector, as chosen by the sub-adviser, Wellington Management Company LLP. The fund adopts a comprehensive strategy for investing within this industry. Its potential investments span a wide array of health-related businesses, including those in pharmaceuticals, biotechnology, medical products, healthcare delivery, medical services, managed care, health information technology, and emerging h... ## Key Facts | Metric | Value | |---|---| | Price | $54.90 | | Expense Ratio | 1.05% | | AUM (All Share Classes) | $790.0M | | NAV | $54.90 | | Holdings Count | — | | Distribution Yield (TTM) | 2.56% | | Annual Distribution (TTM) | $1.40 /share | | Distribution Frequency | Annual | | 52-Week Range | $44.75 – $55.77 | | Beta | 0.61 | ## Latest Distribution - Amount: $1.4032 /share - Ex-date: 2025-12-11 - Pay date: 2025-12-12 ## Frequently Asked Questions ### What does HGHYX invest in? The fund aims to achieve substantial long-term capital appreciation. Under normal circumstances, a minimum of 80% of its portfolio is allocated to equity holdings in global companies tied to the healthcare sector, as chosen by the sub-adviser, Wellington Management Company LLP. The fund adopts a comprehensive strategy for investing within this industry. Its potential investments span a wide array of health-related businesses, including those in pharmaceuticals, biotechnology, medical products, healthcare delivery, medical services, managed care, health information technology, and emerging health subsectors. ### What is the expense ratio of HGHYX? The Hartford Healthcare Fd Cl Y (HGHYX) charges an expense ratio of 1.05%. This is the annual fee deducted from fund assets to cover management and operations. ### How big is HGHYX? The Hartford Healthcare Fd Cl Y (HGHYX) is one share class of a fund that manages $790.0M across all of its share classes (HGHAX reports the same total). Our data does not carry the assets of this share class alone. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation. ### Is HGHYX actively managed or an index fund? HGHYX is actively managed: the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (HGHYX's is 1.05%) in exchange for the discretion to over- or under-weight positions. ### When was HGHYX launched? The Hartford Healthcare Fd Cl Y (HGHYX) launched in April 2000 and is managed by Hartford. ### How has HGHYX performed? HGHYX's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon. ### Does HGHYX pay a dividend? The Hartford Healthcare Fd Cl Y (HGHYX) currently distributes little or no income. Trailing-twelve-month yield is 2.56%. Investors looking for income should consider income-focused alternatives. See the Peers tab. ### How often does HGHYX pay dividends? The Hartford Healthcare Fd Cl Y pays dividends Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page. ### What is HGHYX's dividend yield? HGHYX's trailing-twelve-month yield is 2.56%, calculated from the sum of dividends over the past year divided by the current price. ### When is HGHYX's next ex-dividend date? The most recently announced ex-dividend date for HGHYX was 2025-12-11. The next ex-date typically follows Annual; once announced it appears at the top of the dividend history table on this page. ### How much will HGHYX's expense ratio cost me over 30 years? On a $10,000 investment compounding at 7% gross return, a 1.05% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees. ### How does HGHYX charge its expense ratio? The expense ratio is deducted in tiny daily slices from HGHYX's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price. ### Why does HGHYX cost more than a fund like VOO? HGHYX is actively managed (current expense ratio 1.05%). Active funds charge more than passive index trackers in exchange for the manager's discretion to over- or under-weight positions. The Cost Verdict card above tells you whether HGHYX's fee is competitive for the active-management cohort. ### Are there cheaper alternatives to HGHYX? The Lower-Fee Alternatives card above lists mutual funds following the same investment strategy as HGHYX (1.05%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want. ## More on Dividend Data - Overview (HTML): https://www.dividenddata.com/funds/hghyx - Distribution history: https://www.dividenddata.com/funds/hghyx/dividend - Holdings & diversification: https://www.dividenddata.com/funds/hghyx/diversification - Fees & cheaper alternatives: https://www.dividenddata.com/funds/hghyx/expenses - Peer comparison: https://www.dividenddata.com/funds/hghyx/peers Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.